The role of neoadjuvant therapy for resectable pancreatic cancer remains uncertain

被引：0
|
作者：
Christoph Springfeld
John P. Neoptolemos
机构：
[1] Heidelberg University Hospital,Department of Medical Oncology, National Center for Tumor Diseases
[2] Heidelberg University Hospital,Department of Surgery
来源：
Nature Reviews Clinical Oncology | 2022年 / 19卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Patients with pancreatic ductal adenocarcinoma (PDAC) usually have a dismal prognosis, and even after curative resection most patients will have disease relapse and ultimately die. Nonetheless, adjuvant chemotherapy has considerably improved the outcomes of patients who are able to undergo surgery. The PREOPANC trial provides some evidence supporting the use of neoadjuvant therapy for patients with borderline resectable PDACs but not, as claimed, for those with resectable tumours.
引用
收藏
页码：285 / 286
页数：1
相关论文
共 50 条
  • [31] Outcome Following Neoadjuvant Therapy for Borderline Resectable Pancreatic Cancer
    Stokes, J. B.
    Walters, D. M.
    Norris, N. J.
    Stelow, E. B.
    Rich, T. A.
    Weiss, G. R.
    De Lange, E. E.
    Adams, R. B.
    Bauer, T. W.
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2009, 16 : 80 - 80
  • [32] Contemporary trials evaluating neoadjuvant therapy for resectable pancreatic cancer
    Chawla, Akhil
    [J]. JOURNAL OF SURGICAL ONCOLOGY, 2021, 123 (06) : 1423 - 1431
  • [33] A Paradigm Shifts: Neoadjuvant Therapy for Clearly Resectable Pancreatic Cancer
    de Geus, Susanna W. L.
    Sachs, Teviah E.
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2023, 30 (06) : 3427 - 3436
  • [34] Neoadjuvant Therapy for Potentially Resectable Pancreatic Cancer: An Emerging Paradigm?
    Thomas B. Brunner
    [J]. Current Oncology Reports, 2013, 15 : 162 - 169
  • [35] Neoadjuvant Therapy for Potentially Resectable Pancreatic Cancer: An Emerging Paradigm?
    Brunner, Thomas B.
    [J]. CURRENT ONCOLOGY REPORTS, 2013, 15 (02) : 162 - 169
  • [36] NEOADJUVANT THERAPY VERSUS SURGERY FIRST FOR RESECTABLE PANCREATIC CANCER
    Almerey, Tariq
    Hyman, David
    Li, Zhuo
    Tice, Mary
    Porrazzo, Gina
    Stauffer, John
    [J]. GASTROENTEROLOGY, 2023, 164 (06) : S1538 - S1538
  • [37] Neoadjuvant therapy in resectable pancreatic cancer-is this the way forward?
    Perri, Giampaolo
    Marchegiani, Giovanni
    Malleo, Giuseppe
    Salvia, Roberto
    [J]. CHINESE CLINICAL ONCOLOGY, 2021, 10 (05)
  • [38] Neoadjuvant therapy for resectable pancreatic cancers
    Inoue, Yosuke
    Ito, Hiromichi
    Takahashi, Yu
    [J]. HEPATOBILIARY SURGERY AND NUTRITION, 2022, 11 (04) : 583 - 585
  • [39] Role of Chemoradiotherapy in the Adjuvant and Neoadjuvant Settings for Resectable Pancreatic Cancer
    Sen, N.
    Falk, S.
    Abrams, R. A.
    [J]. CLINICAL ONCOLOGY, 2014, 26 (09) : 551 - 559
  • [40] The role of neoadjuvant therapy in surgically resectable esophageal cancer
    Swisher, SG
    Holmes, EC
    Hunt, KK
    Doty, JE
    Zinner, MJ
    McFadden, DW
    [J]. ARCHIVES OF SURGERY, 1996, 131 (08) : 819 - 824
12345